Elevance Health, Inc.·4

Apr 25, 5:05 PM ET

Norwood Felicia F 4

4 · Elevance Health, Inc. · Filed Apr 25, 2024

Insider Transaction Report

Form 4
Period: 2024-04-23
Norwood Felicia F
EVP &Chief Health Benefits Ofr
Transactions
  • Exercise/Conversion

    Common Stock

    2024-04-24$238.27/sh+2,043$486,78633,503 total
  • Sale

    Common Stock

    2024-04-23$533.73/sh14,011$7,478,09131,560 total
  • Exercise/Conversion

    Common Stock

    2024-04-23$238.27/sh+5,473$1,304,05245,571 total
  • Sale

    Common Stock

    2024-04-23$534.74/sh100$53,47431,460 total
  • Sale

    Common Stock

    2024-04-24$532.14/sh2,765$1,471,36730,738 total
  • Sale

    Common Stock

    2024-04-24$532.68/sh3,434$1,829,22327,304 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2024-04-235,4732,043 total
    Exercise: $238.27Exp: 2028-07-02Common Stock (5,473 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2024-04-242,0430 total
    Exercise: $238.27Exp: 2028-07-02Common Stock (2,043 underlying)
Footnotes (4)
  • [F1]This transaction was executed in multiple trades at prices ranging from $533.60 to $534.52. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]This transaction was executed in multiple trades at prices ranging from $531.44 to $532.43. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]This transaction was executed in multiple trades at prices ranging from $532.44 to $533.30. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]Fully vested.

Documents

1 file
  • 4
    form4-04252024_090423.xmlPrimary